JMP Securities Maintains Market Outperform on Minerva Neurosciences, Lowers Price Target to $18

JMP Securities maintains Minerva Neurosciences (NASDAQ:NERV) with a Market Outperform and lowers the price target from $20 to $18.

Benzinga · 12/19/2019 15:02

JMP Securities maintains Minerva Neurosciences (NASDAQ:NERV) with a Market Outperform and lowers the price target from $20 to $18.